According to our research analysis, North America clinical diagnostics market 2021-2031 is projected to grow by 6.6 % annually in the forecast period and reach USD 53,670.4 million by 2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.
Highlighted with 23 tables and 58 figures, this 108-page report North America Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.
Based on Test, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
- Lipid Panel
- Infectious Disease Testing
- Liver Panel
- Complete Blood Count (CBC)
- Electrolyte Testing
- Renal Panel
- Other Tests
Based on Product, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
- Instruments
- Assay Kits & Reagents
- Software & Services
Get Free Sample Report @
https://kenresearch.com/sample-report.php?Frmdetails=NTMyMjg3
By Indication the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
- Cardiovascular
- Cancer
- Infectious Disease
- Stroke
- Chronic Lower Respiratory Diseases
- Diabetes
- Other Indications
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
- Selected Key Players:
- Abbott Laboratories
- Becton, Dickinson and Company
- BioMerieux SA
- Bio-Rad Laboratories Inc.
For More Information, refer to below link: – 
North America Clinical Diagnostics Market Future Outlook
Related Report:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us: –
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249